Navigation Links
YM BIOSCIENCES REPORTS 2007 YEAR END OPERATIONAL AND FINANCIAL RESULTS
Date:9/23/2007

Share purchase warrants 4,553,308 4,597,988

Contributed surplus 5,657,082 3,944,492

Deficit accumulated during the

development stage (118,296,741) (86,566,501)

-----------------------------------------------------------------------

64,834,802 94,747,523

Basis of presentation

Commitments

-------------------------------------------------------------------------

$ 81,739,800 $ 100,048,060

-------------------------------------------------------------------------

-------------------------------------------------------------------------

YM BIOSCIENCES INC.

(A DEVELOPMENT STAGE COMPANY)

Consolidated Statements of Operations and

Deficit Accumulated During the Development Stage

(Amounts in Canadian dollars, unless otherwise noted)

-------------------------------------------------------------------------

Period from

inception on

August 17,

1994

Years ended June 30, to June 30,

2007 2006 2005 2007

-------------------------------------------------------------------------

Revenue $ 4,407,890 $ 1,151,135 $ 748,020 $ 6,307,045

Interest

income 3,239,540 1,397,558 703,873 8,129,389

-------------------------------------------------------------------------

7,647,430 2,548,693 1,451,893 14,436,434


'/>"/>

SOURCE YM BioSciences Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Perscitus Biosciences secures $250K Commerce loan
2. Wisconsin biosciences rise to the challenge
3. Quintessence Biosciences advances cancer drug
4. Quintessence Biosciences names new president
5. Caden Biosciences may signal critical mass
6. Wisconsin start up Primorigen Biosciences corrals out-of-state investment
7. WARF signs licensing pact with BD Biosciences
8. Fisher Biosciences contracts with Madison-based GenTel BioSurfaces
9. State awards QRG Biosciences development grant
10. EMD Biosciences partners with European biotech company
11. Quintessence Biosciences forms cancer therapeutic advisory board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... , Sept. 23, 2014 News ... India devoted to genome-based research for ... Genomics (NIBMG) is taking a bite out of oral ... among males in India with the ... solutions from DataDirect Networks (DDN). , To fuel its ...
(Date:9/23/2014)... WASHINGTON, New York , September 23, 2014 ... ), a leading provider of  Closed System Transfer   ... a new exclusive partnership with Taiwanese distributor MedFront Medical Technology ... regulatory bodies in Taiwan , ... for approval as the company continues to expand ...
(Date:9/23/2014)... September 23, 2014 The Minnesota ... developer of cellular modems , platforms and ... the Startup category for the 2014 Tekne Awards. ... at the Minneapolis Convention Center on Thursday, November ... individuals who have shown superior technology innovation and ...
(Date:9/22/2014)... 2014 Research and Markets ... the "Global Biotechnology Reagents Market 2014-2018" ... http://photos.prnewswire.com/prnh/20130307/600769) Biotechnology reagents are chemical compounds ... to detect and examine another substance to provide ... laboratories to prepare, collect, and examine specimens from ...
Breaking Biology Technology:National Institute of Biomedical Genomics (NIBMG) Deploys DataDirect Networks Storage to Achieve Significant Performance Improvement in World-Class Genomics Research and Collaboration for Oral Cancer 2National Institute of Biomedical Genomics (NIBMG) Deploys DataDirect Networks Storage to Achieve Significant Performance Improvement in World-Class Genomics Research and Collaboration for Oral Cancer 3National Institute of Biomedical Genomics (NIBMG) Deploys DataDirect Networks Storage to Achieve Significant Performance Improvement in World-Class Genomics Research and Collaboration for Oral Cancer 4National Institute of Biomedical Genomics (NIBMG) Deploys DataDirect Networks Storage to Achieve Significant Performance Improvement in World-Class Genomics Research and Collaboration for Oral Cancer 5Equashield Enters Taiwan Following Expansion to Australia, Japan, China 2NimbeLink Named Finalist for 15th Annual Tekne Awards 2NimbeLink Named Finalist for 15th Annual Tekne Awards 3Global Biotechnology Reagents Market 2014-2018: Key Vendors are Agilent, BD Biosciences, Bio-Rad, F. Hoffmann-La Roche, Sigma-Aldrich and Thermo Fisher 2Global Biotechnology Reagents Market 2014-2018: Key Vendors are Agilent, BD Biosciences, Bio-Rad, F. Hoffmann-La Roche, Sigma-Aldrich and Thermo Fisher 3
... GeoVax Labs, Inc. (OTC,Bulletin Board: GOVX), an Atlanta-based biotechnology ... an,operational update for the quarter ended June 30, 2007. ... 2007 The Company recorded a net loss of ... to net income of $197,750 for the same period,in ...
... Transgenomic, Inc. (the,"Company") (OTC Bulletin Board: TBIO) today ... The Company,s financial results are,presented in the tables that ... a net profit of $0.2 million or $0.00 per ... a net loss of $0.4 million or,$0.01 per share ...
... Martek Biosciences,Corporation announced that it intends to release ... September 5, 2007, at approximately 4:00 p.m.,Eastern Daylight Time ... hold a conference call to discuss the results of ... is expected to be approximately one,hour in duration. The ...
Cached Biology Technology:GeoVax Labs, Inc. Second Quarter Financial Results and Operational Update 2GeoVax Labs, Inc. Second Quarter Financial Results and Operational Update 3GeoVax Labs, Inc. Second Quarter Financial Results and Operational Update 4GeoVax Labs, Inc. Second Quarter Financial Results and Operational Update 5GeoVax Labs, Inc. Second Quarter Financial Results and Operational Update 6Transgenomic, Inc. Reports Second Quarter 2007 Results 2Transgenomic, Inc. Reports Second Quarter 2007 Results 3Transgenomic, Inc. Reports Second Quarter 2007 Results 4Transgenomic, Inc. Reports Second Quarter 2007 Results 5Transgenomic, Inc. Reports Second Quarter 2007 Results 6Transgenomic, Inc. Reports Second Quarter 2007 Results 7Transgenomic, Inc. Reports Second Quarter 2007 Results 8Martek to Announce Third Quarter 2007 Results on September 5, 2007 2
(Date:9/23/2014)... proteins to survive in the icy Southern Ocean ... by the National Science Foundation (NSF) report: The ... resist melting even when temperatures warm. , ... consequence of the evolution of antifreeze proteins in ... student Paul Cziko, who led the research with ...
(Date:9/23/2014)... the body forms new tissues during the healing ... each other. For years, scientists believed this communication ... Carnegie Mellon University and the University of Pittsburgh ... is equally if not more crucial. The ... Proceedings of the National Academy of Sciences ...
(Date:9/23/2014)... have scoured cow rumens and termite guts for microbes ... the production of next-generation biofuels, but some of the ... lower intestine, researchers report. , Their study , ... of Sciences , is the first to use biochemical ... human gut can digest fiber, breaking it down into ...
Breaking Biology News(10 mins):Antifreeze proteins in Antarctic fish prevent both freezing and melting 2Antifreeze proteins in Antarctic fish prevent both freezing and melting 3The mechanics of tissue growth 2Search for better biofuels microbes leads to the human gut 2Search for better biofuels microbes leads to the human gut 3
... Liver transplant patients with hepatitis C virus (HCV) ... the immunosuppressive agent Cyclosporine along with interferon-ribavirin combination ... virus in vitro. , The results of ... of Liver Transplantation, the official journal of the ...
... infants born with HIV infection may be most effective ... according to a study published in the April 1 ... online. , Uncertainty over when to start antiretroviral treatment ... around balancing the benefits of preventing disease progression and ...
... in which single strands of synthetic DNA are used ... been developed by researchers with the Lawrence Berkeley National ... Berkeley. This technique holds promise for a wide ... of artificial tissues and the design of neural networks. ...
Cached Biology News:Cyclosporine inhibits hepatitis C virus in vitro 2New study shows benefit of early therapy in HIV-infected infants 2Berkeley researchers lay groundwork for cell version of DNA chip 2Berkeley researchers lay groundwork for cell version of DNA chip 3Berkeley researchers lay groundwork for cell version of DNA chip 4
...
Recalibration of HL-2000-CAL products...
Mature rat whole blood (Sprague-Dawley, averaging 7-8 weeks of age, either sex) is collected at the time of slaughter and processed within 45 minutes. It is then filtered through gauze, pooled in an ...
Several Pichia pastoris strains are available to allow you to optimize expression and recovery of your protein of interest. Table 1 provides information to help you choose the appropriate strain....
Biology Products: